AbbVie, Arch Capital, Gilead Sciences And A Telecom Giant On CNBC's 'Final Trades' - Arch Capital Group (NASDAQ:ACGL), AbbVie (NYSE:ABBV)

On CNBC’s "Halftime Report Final Trades," Rob Sechan of NewEdge Wealth said Gilead Sciences, Inc.

Related Keywords

Jenny Harrington ,Jim Lebenthal ,Joseph Terranova ,Jeffrey Stewart ,Pharma Inc ,Rob Sechan ,Brian Meredith ,Verizon ,Arch Capital Group Ltd ,Gilead Sciences Inc ,Gilead Sciences ,Arch Capital Group ,Abbvie Inc ,Verizon Communications Inc ,Verizon Communications ,Report Final Trades ,Newedge Wealth ,Cerity Partners ,Chief Commercial Officer Jeffrey Stewart ,Gilman Hill Asset Management ,Virtus Investment Partners ,Arch Capital ,